Skip to main content
Top
Published in: Documenta Ophthalmologica 3/2024

17-04-2024 | Night-Blindness | Clinical Case Report

Clinical course of two siblings with potassium voltage-gated channel modifier subfamily V member 2 (KCNV2)-associated retinopathy

Authors: Tomoko Sato, Kazuki Kuniyoshi, Takaaki Hayashi, Hirokazu Nishiwaki, Kei Mizobuchi, Shunji Kusaka

Published in: Documenta Ophthalmologica | Issue 3/2024

Login to get access

Abstract

Background

KCNV2-associated retinopathy causes a phenotype reported as “cone dystrophy with nyctalopia and supernormal rod responses (CDSRR; OMIM# 610356),” featuring pathognomonic findings on electroretinography (ERG). Here, we report the clinical courses of two siblings with CDSRR.

Case reports

Patient 1: A 3-year-old boy with intermittent exophoria was referred to our hospital. The patient’s decimal best-corrected visual acuity (BCVA) at age 6 was 0.7 and 0.7 in the right and left eyes, respectively. Photophobia and night blindness were also observed. Because the ERG showed a delayed and supernormal b-wave with a “squaring (trough-flattened)” a-wave in the DA-30 ERG, and CDSRR was diagnosed. The patient’s vision gradually worsened, and faint bilateral bull’s eye maculopathy was observed at the age of 27 years, although the fundi were initially unremarkable. Genetic examination revealed a homozygous missense variant, c.529T > C (p.Cys177Arg), in the KCNV2 gene.
Patient 2: The second patient was Patient 1’s younger sister, who was brought to our hospital at 3 years of age. The patient presented with exotropia, mild nystagmus, photophobia, night blindness, and color vision abnormalities. The patients’ decimal BCVA at age 13 was 0.6 and 0.4 in the right and left eyes, respectively, and BCVA gradually decreased until the age of 24 years. The fundi were unremarkable. The siblings had similar ERG findings and the same homozygous missense variant in the KCNV2 gene.

Conclusions

The siblings had clinical findings typical of CDSRR. High-intense flash ERG is recommended for identifying pathognomonic “squaring” a-waves in patients with CDSRR.
Literature
1.
go back to reference Gouras P, Eggers HM, MacKay CJ (1983) Cone dystrophy, nyctalopia, and supernormal rod responses. A new retinal degeneration. Arch Ophthalmol 101:718–724CrossRefPubMed Gouras P, Eggers HM, MacKay CJ (1983) Cone dystrophy, nyctalopia, and supernormal rod responses. A new retinal degeneration. Arch Ophthalmol 101:718–724CrossRefPubMed
2.
go back to reference Rosenberg T, Simonsen SE (1993) Retinal cone dysfunction of supernormal rod ERG type. Five new cases. Acta Ophthalmol (Copenh) 71:246–255CrossRefPubMed Rosenberg T, Simonsen SE (1993) Retinal cone dysfunction of supernormal rod ERG type. Five new cases. Acta Ophthalmol (Copenh) 71:246–255CrossRefPubMed
3.
go back to reference Michaelides M, Holder GE, Webster AR, Hunt DM, Bird AC, Fitzke FW et al (2005) A detailed phenotypic study of “cone dystrophy with supernormal rod ERG”. Br J Ophthalmol 89:332–339CrossRefPubMedPubMedCentral Michaelides M, Holder GE, Webster AR, Hunt DM, Bird AC, Fitzke FW et al (2005) A detailed phenotypic study of “cone dystrophy with supernormal rod ERG”. Br J Ophthalmol 89:332–339CrossRefPubMedPubMedCentral
4.
go back to reference Georgiou M, Robson AG, Fujinami K, Leo SM, Vincent A, Nasser F et al (2020) KCNV2-associated retinopathy: genetics, electrophysiology, and clinical course-KCNV2 Study Group Report 1. Am J Ophthalmol 225:95–107CrossRefPubMed Georgiou M, Robson AG, Fujinami K, Leo SM, Vincent A, Nasser F et al (2020) KCNV2-associated retinopathy: genetics, electrophysiology, and clinical course-KCNV2 Study Group Report 1. Am J Ophthalmol 225:95–107CrossRefPubMed
5.
go back to reference Georgiou M, Fujinami K, Vincent A, Nasser F, Khateb S, Vargas ME et al (2021) KCNV2-associated retinopathy: detailed retinal phenotype and structural endpoints-KCNV2 Study Group Report 2. Am J Ophthalmol 230:1–11CrossRefPubMedPubMedCentral Georgiou M, Fujinami K, Vincent A, Nasser F, Khateb S, Vargas ME et al (2021) KCNV2-associated retinopathy: detailed retinal phenotype and structural endpoints-KCNV2 Study Group Report 2. Am J Ophthalmol 230:1–11CrossRefPubMedPubMedCentral
6.
go back to reference Hood DC, Cideciyan AV, Halevy DA, Jacobson SG (1996) Sites of disease action in a retinal dystrophy with supernormal and delayed rod electroretinogram b-waves. Vision Res 36:889–901CrossRefPubMed Hood DC, Cideciyan AV, Halevy DA, Jacobson SG (1996) Sites of disease action in a retinal dystrophy with supernormal and delayed rod electroretinogram b-waves. Vision Res 36:889–901CrossRefPubMed
7.
go back to reference Fujinami K, Tsunoda K, Nakamura N, Kato Y, Noda T, Shinoda K et al (2013) Molecular characteristics of four Japanese cases with KCNV2 retinopathy: report of novel disease-causing variants. Mol Vis 19:1580–1590PubMedPubMedCentral Fujinami K, Tsunoda K, Nakamura N, Kato Y, Noda T, Shinoda K et al (2013) Molecular characteristics of four Japanese cases with KCNV2 retinopathy: report of novel disease-causing variants. Mol Vis 19:1580–1590PubMedPubMedCentral
8.
go back to reference Wu H, Cowing JA, Michaelides M, Wilkie SE, Jeffery G, Jenkins SA et al (2006) Mutations in the gene KCNV2 encoding a voltage-gated potassium channel subunit cause “cone dystrophy with supernormal rod electroretinogram” in humans. Am J Hum Genet 79:574–579CrossRefPubMedPubMedCentral Wu H, Cowing JA, Michaelides M, Wilkie SE, Jeffery G, Jenkins SA et al (2006) Mutations in the gene KCNV2 encoding a voltage-gated potassium channel subunit cause “cone dystrophy with supernormal rod electroretinogram” in humans. Am J Hum Genet 79:574–579CrossRefPubMedPubMedCentral
9.
go back to reference Robson AG, Frishman LJ, Grigg J, Hamilton R, Jeffrey BG, Kondo M et al (2022) ISCEV Standard for full-field clinical electroretinography (2022 update). Doc Ophthalmol 144:165–177CrossRefPubMedPubMedCentral Robson AG, Frishman LJ, Grigg J, Hamilton R, Jeffrey BG, Kondo M et al (2022) ISCEV Standard for full-field clinical electroretinography (2022 update). Doc Ophthalmol 144:165–177CrossRefPubMedPubMedCentral
10.
go back to reference Johnson MA, Jeffrey BG, Messias AMV, Robson AG (2019) ISCEV extended protocol for the stimulus-response series for the dark-adapted full-field ERG b-wave. Doc Ophthalmol 138:217–227CrossRefPubMed Johnson MA, Jeffrey BG, Messias AMV, Robson AG (2019) ISCEV extended protocol for the stimulus-response series for the dark-adapted full-field ERG b-wave. Doc Ophthalmol 138:217–227CrossRefPubMed
11.
go back to reference Hayashi T, Mizobuchi K, Kikuchi S, Nakano T (2021) Novel biallelic TRPM1 variants in an elderly patient with complete congenital stationary night blindness. Doc Ophthalmol 142:265–273CrossRefPubMed Hayashi T, Mizobuchi K, Kikuchi S, Nakano T (2021) Novel biallelic TRPM1 variants in an elderly patient with complete congenital stationary night blindness. Doc Ophthalmol 142:265–273CrossRefPubMed
12.
go back to reference Mizobuchi K, Hayashi T, Matsuura T, Nakano T (2022) Clinical characterization of autosomal dominant retinitis pigmentosa with NRL mutation in a three-generation Japanese family. Doc Ophthalmol 144:227–235CrossRefPubMed Mizobuchi K, Hayashi T, Matsuura T, Nakano T (2022) Clinical characterization of autosomal dominant retinitis pigmentosa with NRL mutation in a three-generation Japanese family. Doc Ophthalmol 144:227–235CrossRefPubMed
13.
go back to reference Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405–424CrossRefPubMedPubMedCentral Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405–424CrossRefPubMedPubMedCentral
14.
go back to reference Abdelkader E, Yasir ZH, Khan AM, Raddadi O, Khandekar R, Alateeq N et al (2020) Analysis of retinal structure and function in cone dystrophy with supernormal rod response. Doc Ophthalmol 141:23–32CrossRefPubMed Abdelkader E, Yasir ZH, Khan AM, Raddadi O, Khandekar R, Alateeq N et al (2020) Analysis of retinal structure and function in cone dystrophy with supernormal rod response. Doc Ophthalmol 141:23–32CrossRefPubMed
15.
go back to reference Wissinger B, Dangel S, Jägle H, Hansen L, Baumann B, Rudolph G et al (2008) Cone dystrophy with supernormal rod response is strictly associated with mutations in KCNV2. Invest Ophthalmol Vis Sci 49:751–757CrossRefPubMed Wissinger B, Dangel S, Jägle H, Hansen L, Baumann B, Rudolph G et al (2008) Cone dystrophy with supernormal rod response is strictly associated with mutations in KCNV2. Invest Ophthalmol Vis Sci 49:751–757CrossRefPubMed
16.
go back to reference Friedburg C, Wissinger B, Schambeck M, Bonin M, Kohl S, Lorenz B (2011) Long-term follow-up of the human phenotype in three siblings with cone dystrophy associated with a homozygous p. G461R mutation of KCNV2. Invest Ophthalmol Vis Sci 52:8621–8629CrossRefPubMed Friedburg C, Wissinger B, Schambeck M, Bonin M, Kohl S, Lorenz B (2011) Long-term follow-up of the human phenotype in three siblings with cone dystrophy associated with a homozygous p. G461R mutation of KCNV2. Invest Ophthalmol Vis Sci 52:8621–8629CrossRefPubMed
17.
go back to reference Nakamura N, Tsunoda K, Fujinami K, Shinoda K, Tomita K, Hatase T et al (2013) Long-term observation over ten years of four cases of cone dystrophy with supernormal rod electroretinogram. Nippon Ganka Gakkai Zasshi (J Jpn Ophthalmol Soc) 117:629–640 Nakamura N, Tsunoda K, Fujinami K, Shinoda K, Tomita K, Hatase T et al (2013) Long-term observation over ten years of four cases of cone dystrophy with supernormal rod electroretinogram. Nippon Ganka Gakkai Zasshi (J Jpn Ophthalmol Soc) 117:629–640
18.
go back to reference Lie H, Wang G, Liu X, Meng X, Long Y, Ren J et al (2021) Long-term follow-up of a Chinese patient with KCNV2-retinopathy. Ophthalmic Genet 42:144–149CrossRefPubMed Lie H, Wang G, Liu X, Meng X, Long Y, Ren J et al (2021) Long-term follow-up of a Chinese patient with KCNV2-retinopathy. Ophthalmic Genet 42:144–149CrossRefPubMed
19.
go back to reference Czirják G, Tóth ZE, Enyedi P (2007) Characterization of the heteromeric potassium channel formed by Kv2.1 and the retinal subunit Kv8.2 in Xenopus Oocytes. J Neurophysiol 98:1213–1222CrossRefPubMed Czirják G, Tóth ZE, Enyedi P (2007) Characterization of the heteromeric potassium channel formed by Kv2.1 and the retinal subunit Kv8.2 in Xenopus Oocytes. J Neurophysiol 98:1213–1222CrossRefPubMed
20.
go back to reference Winkler BS (1973) Dependence of fast components of the electroretinogram of the isolated rat retina on the ionic environment. Vision Res 13:457–463CrossRefPubMed Winkler BS (1973) Dependence of fast components of the electroretinogram of the isolated rat retina on the ionic environment. Vision Res 13:457–463CrossRefPubMed
21.
go back to reference Hart NS, Mountford JK, Voigt V, Fuller-Carter P, Barth M, Nerbonne JM et al (2019) The role of the voltage-gated potassium channel proteins Kv8.2 and Kv2.1 in vision and retinal disease: insights from the study of mouse gene knock-out mutations. eNeuro. 6:e0032-19CrossRef Hart NS, Mountford JK, Voigt V, Fuller-Carter P, Barth M, Nerbonne JM et al (2019) The role of the voltage-gated potassium channel proteins Kv8.2 and Kv2.1 in vision and retinal disease: insights from the study of mouse gene knock-out mutations. eNeuro. 6:e0032-19CrossRef
22.
go back to reference Jiang X, Rashwan R, Voigt V, Nerbonne J, Hunt DM, Carvalho LS (2021) Molecular, cellular and functional changes in the retinas of young adult mice lacking the voltage-gated K+ channel subunits Kv8.2 and K2.1. Int J Mol Sci 22:4877CrossRefPubMedPubMedCentral Jiang X, Rashwan R, Voigt V, Nerbonne J, Hunt DM, Carvalho LS (2021) Molecular, cellular and functional changes in the retinas of young adult mice lacking the voltage-gated K+ channel subunits Kv8.2 and K2.1. Int J Mol Sci 22:4877CrossRefPubMedPubMedCentral
23.
go back to reference Sudharsan R, Simone KM, Anderson NP, Aguirre GD, Beltran WA (2017) Acute and protracted cell death in light-induced retinal degeneration in the canine model of rhodopsin autosomal dominant retinitis pigmentosa. Invest Ophthalmol Vis Sci 58:270–281CrossRefPubMedPubMedCentral Sudharsan R, Simone KM, Anderson NP, Aguirre GD, Beltran WA (2017) Acute and protracted cell death in light-induced retinal degeneration in the canine model of rhodopsin autosomal dominant retinitis pigmentosa. Invest Ophthalmol Vis Sci 58:270–281CrossRefPubMedPubMedCentral
24.
go back to reference Kaizuka C, Hayashi T, Mizobuchi K, Kubota M, Ueno S, Nakano T (2021) Transient electroretinographic abnormalities that mimic those of KCNV2 retinopathy: a case report. Doc Ophthalmol 143:221–228CrossRefPubMedPubMedCentral Kaizuka C, Hayashi T, Mizobuchi K, Kubota M, Ueno S, Nakano T (2021) Transient electroretinographic abnormalities that mimic those of KCNV2 retinopathy: a case report. Doc Ophthalmol 143:221–228CrossRefPubMedPubMedCentral
25.
go back to reference Nagae Y, Kuniyoshi K, Ishibashi M, Tanabe F, Matsumoto C, Kusaka S (2023) Fundus autofluorescence, optical coherence tomography and electroretinography abnormalities in a patient with digoxin retinopathy that resemble those in KCNV2-associated retinopathy. Doc Ophthalmol 147:131–137CrossRefPubMed Nagae Y, Kuniyoshi K, Ishibashi M, Tanabe F, Matsumoto C, Kusaka S (2023) Fundus autofluorescence, optical coherence tomography and electroretinography abnormalities in a patient with digoxin retinopathy that resemble those in KCNV2-associated retinopathy. Doc Ophthalmol 147:131–137CrossRefPubMed
Metadata
Title
Clinical course of two siblings with potassium voltage-gated channel modifier subfamily V member 2 (KCNV2)-associated retinopathy
Authors
Tomoko Sato
Kazuki Kuniyoshi
Takaaki Hayashi
Hirokazu Nishiwaki
Kei Mizobuchi
Shunji Kusaka
Publication date
17-04-2024
Publisher
Springer Berlin Heidelberg
Published in
Documenta Ophthalmologica / Issue 3/2024
Print ISSN: 0012-4486
Electronic ISSN: 1573-2622
DOI
https://doi.org/10.1007/s10633-024-09971-0

Other articles of this Issue 3/2024

Documenta Ophthalmologica 3/2024 Go to the issue